Inhibition of cyclooxygenase-2 and inducible nitric oxide synthase by silymarin in proliferating mesenchymal stem cells: Comparison with glutathione modifiers

Journal of Natural Medicines

Volumn 66, Issue 1, 2012, Pages 85-94

  Ahmadi Ashtiani, Hamidreza ^a   Allameh, Abdolamir ^a   Rastegar, Hosein ^b   Soleimani, Masoud ^a   Barkhordari, Elham ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cellular redox; Cyclooxygenase 2; Glutathione; Inducible nitric oxide synthase; Mesenchymal stem cells; Proliferation; Silymarin

Indexed keywords

ACETYLCYSTEINE; AGENTS AFFECTING PROTEIN METABOLISM; BUTHIONINE SULFOXAMINE; CYCLOOXYGENASE 2; GLUTATHIONE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; SILYMARIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG TARGETING; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL;

EID: 84856209536     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-011-0554-6     Document Type: Article

References (55)

1. Matsuda T, Ferreri K, Todorov I, Kuroda Y, Smith CV, Kandeel F, Mullen Y (2005) Silymarin protects pancreatic b-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology 146(1):175-185 (Pubitemid 40051737)
2. 2 exposure in erythrocytes. Basic Clin Pharmacol Toxicol 100:414-419 (Pubitemid 46776391)
3. Fraschini F, Demartini G, Esposti D (2002) Pharmacology of silymarin. Clin Drug Invest 22(1):51-65 (Pubitemid 34151333)
4. Jones DP (2002) Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 348:93-112 (Pubitemid 41103102)
5. Walter HW, Yan C, Dean PJ (2003) Redox state of glutathione and thioredoxin in differentiation and apoptosis. BioFactors 17:307-314
6. Yuan Y, Tzeng E, Billiar TR (2006) Distinct roles of different nitric oxide synthase isoforms in regulating hematopoietic stem cell function in vivo. Nitric Oxide 14:7
7. Lee HW, Kim SY, Kim AY, Lee EJ, Choi JY, Kim JB (2009) Tissue-specific stem cells adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells 27(9):2254-2262
8. Libby P, Warner SJ, Friedman GB (1988) Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth inhibitory prostanoids. J Clin Invest 81:487-498 (Pubitemid 18075245)
9. Schror K, Weber AA (1997) Roles of vasodilatory prostaglandins in mitogenesis of vascular smooth muscle cells. Agents Actions Suppl 48:63-91 (Pubitemid 27230356)
10. Yan Z, Hansson GK (1998) Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 82:21-29 (Pubitemid 28074015)
11. Rizvi MA, Myers PR (1997) Nitric oxide modulates basal and endothein-induced coronary artery vascular smooth muscle cell proliferation and collagen levels. J Mol Cell Cardiol 29:1779-1789 (Pubitemid 27303084)
12. Gansauge S, Gansauge F, Nussler AK, Rau B, Poch B, Schoenberg MH, Beger HG (1997) Exogenous, but not endogenous, nitric oxide increases proliferation rates in senescent human fibroblasts. FEBS Lett 410:160-164 (Pubitemid 27304056)
13. Sigala F, Papalambros E, Kotsinas A, Andreadou I, Sigalas P, Kremastinos D, Bastounis E, Gorgoulis VG (2005) Relationship between iNOS expression and aortic cell proliferation and apoptosis in an elastase-induced model of aorta aneurysm and the effect of 1400 W administration. Surgery 137(4):447-456 (Pubitemid 40432044)
14. Kasper HU, Wolf H, Drebber U, Wolf HK, Kern MA (2004) Expression of inducible nitric oxide synthase and cyclooxygenase- 2 in pancreatic adenocarcinoma: correlation with microvessel density. World J Gastroenterol 10(13):1918-1922 (Pubitemid 39029293)
15. Abe T, Hikiji H, Shin WS, Koshikiya N, Shima S, Nakata J, Susami T, Takato T, Toyo-oka T (2003) Targeting of iNOS with antisense DNA plasmid reduces cytokine-induced inhibition of osteoblastic activity. Am J Physiol Endocrinol Metab 285(3):E614-E621 (Pubitemid 37010841)
16. Kolodziejski PJ, Koo JS, Eissa NT (2004) Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc Natl Acad Sci USA 101(52):18141-18146 (Pubitemid 40054087)
17. Kang JS, Jeon YJ, Kim HM, Han SH, Yang KH (2002) Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther 302(1):138-144 (Pubitemid 34680431)
18. Zhao J, Sharma Y, Agarwal R (1999) Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion. Mol Carcinog 26(4):321-333
19. Ramakrishnan G, Elinos-Báez CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T (2008) Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma. Mol Cell Biochem 313(1-2):53-61
20. Wellington K, Jarvis B (2001) Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 15(7):465-489 (Pubitemid 32783707)
21. Pradhan SC, Girish C (2006) Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res 124(5):491-504 (Pubitemid 46157708)
22. Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB (2006) Anticancer potential of silymarin: from bench to bed side. Anticancer Res 26(6B):4457-4498 (Pubitemid 46031522)
23. Li LH, Wu LJ, Tashiro SI, Onodera S, Uchiumi F, Ikejima T (2007) Activation of the SIRT1 pathway and modulation of the cell cycle were involved in silymarin's protection against UVinduced A375-S2 cell apoptosis. J Asian Nat Prod Res 9:245-252 (Pubitemid 46933325)
24. Roy S, Kaur M, Agarwal C, Tecklenburg M, Sclafani RA, Agarwal R (2007) p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol Cancer Ther 6(10):2696-2707 (Pubitemid 350058150)
25. Kaur M, Velmurugan B, Tyagi A, Deep G, Katiyar S, Agarwal C, Agarwal R (2009) Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft. Mol Cancer Ther 8(8):2366-2374
26. Deep G, Oberlies NH, Kroll DJ, Agarwal RI (2008) Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Int J Cancer 123(1):41-50 (Pubitemid 351705190)
27. Starvaggi Cucuzza L, Motta M, Miretti S, Macchi E, Martignani E, Accornero P, Baratta M (2010) Positive effect of silymarin on cell growth and differentiation in bovine and murine mammary cells. J Anim Physiol Anim Nutr (Berl) 94(1):111-117
28. Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R (2006) Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin. Oncogene 25(7):1053-1069 (Pubitemid 43277013)
29. Ramakrishnan G, Lo Muzio L, Elinos-Báez CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T (2009) Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif 42(2):229-240
30. Morishima C, Shuhart MC, Wang CC, Paschal DM, Apodaca MC, Liu Y, Sloan DD, Graf TN, Oberlies NH, Lee DY, Jerome KR, Polyak SJ (2010) Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection. Gastroenterology 138(2):671-681
31. Alidoost F, Gharagozloo M, Bagherpour B, Jafarian A, Sajjadi SE, Hourfar H, Moayedi B (2006) Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from b-thalassemia major patients. Int Immunopharmacol 6(8):1305-1310 (Pubitemid 43868191)
32. He Q, Kim J, Sharma RP (2004) Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases. Toxicol Sci 80(2):335-342 (Pubitemid 39136388)
33. Tamayo C, Diamond S (2007) Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.). Integr Cancer Ther 6(2):146-157 (Pubitemid 46871845)
34. Tunca R, Sozmen M, Citil M, Karapehlivan M, Erginsoy S, Yapar K (2009) Pyridine induction of cytochrome P450 1A1, iNOS and metallothionein in Syrian hamsters and protective effects of silymarin. Exp Toxicol Pathol 61(3):243-255
35. Chittezhath M, Deep G, Singh RP, Agarwal C, Agarwal R (2008) Silibinin inhibits cytokine-induced signaling cascades and downregulates inducible nitric oxide synthase in human lung carcinoma A549 cells. Mol Cancer Ther 7(7):1817-1826
36. Wang HJ, Wei XF, Jiang YY, Huang H, Yang Y, Fan SM, Zang LH, Tashiro S, Onodera S, Ikejima T (2010) Silibinin induces the generation of nitric oxide in human breast cancer MCF-7 cells. Free Radic Res 44(5):577-584
37. Kazemnejad S, Allameh A, Soleimani M, Gharehbaghian A, Mohammadi Y, Amirizadeh N, Jazayery M (2009) Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold. J Gastroentrol Hepatol 24:278-287
38. Kim JW, Kim SY, Park SY, Kim YM, Kim JM, Lee MH, Ryu HM (2004) Mesenchymal progenitor cells in the human umbilical cord. Ann Hematol 83(12):733-738 (Pubitemid 39485542)
39. Covas DT, Siufi JLC, Silva ARL (2003) Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 36:1179-1183 (Pubitemid 37236241)
40. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77
41. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502-522
42. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
43. Ahmadi-Ashtiani HR, Allameh A, Hamidipour N, Rastegar H, Soleimani M (2010) Increasing rate of human bone marrow mesenchymal stem cell proliferation in the presence of silymarin. J Med Plants 9(34):156-164
44. Iemata M, Takarada T, Hinoi E, Taniura H, Yoneda Y (2007) Suppression by glutamate of proliferative activity through glutathione depletion mediated by the cysteine/glutamate antiporter in mesenchymal C3H10T1/2 stem cells. J Cell Physiol 213:721-729 (Pubitemid 350058265)
45. Smith J, Ladi E, Mayer-Pröschel M, Noble M (2000) Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci USA 97(18):10032-10037
46. Valenzuela A, Aspillaga M, Vial S, Guerra R (1989) Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Med 55(5):420-422 (Pubitemid 19249809)
47. Ji AR, Ku SY, Cho MS, Kim YY, Kim YJ, Oh SK, Kim SH, Moon SY, Choi YM (2010) Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage. Exp Mol Med 42:175-186
48. Ho YC, Chang YC (2006) Regulation of nicotine-induced cyclooxygenase-2 protein expression in human gingival fibroblasts. Acta Pharmacol Sin 27(4):409-413
49. Jourdan KB, Evans TW, Lamb NJ, Goldstraw P, Mitchell JA (1999) Autocrine function of inducible nitric oxide synthase and cyclooxygenase-2 in proliferation of human and rat pulmonary artery smooth-muscle cells. Am J Respir Cell Mol Biol 21(1):105-110 (Pubitemid 129508633)
50. Yang X, Sheares KK, Davie N, Upton PD, Taylor GW, Horsley J, Wharton J, Morrell NW (2002) Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 27(6):688-696 (Pubitemid 35381177)
51. Xu Z, Choudhary S, Voznesensky O, Mehrotra M, Woodard M, Hansen M, Herschman H, Pilbeam C (2006) Overexpression of Cox-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Cancer Res 66(13):6657-6664 (Pubitemid 44085622)
52. Wang R, Wang X, Lin F, Gao P, Dong K, Zhang HZ (2008) shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells. Mol Cell Biochem 317:179-188
53. Collesellia D, Bijuklicb K, Mosheimerb BA, Kählera CM (2006) Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation. Exp Cell Res 312(15):2933-2941
54. Harbrecht BG, Di Silvio M, Chough V, Kim YM, Simmons RL, Billiar TR (1997) Glutathione regulates nitric oxide synthase in cultured hepatocytes. Ann Surg 225(1):76-87 (Pubitemid 27026806)
55. Chen G, Wang S, Warner T (2000) Regulation of iNOS mRNA levels in endothelial cells by glutathione, a double-edged sword. Free Radic Res 32(3):223-234 (Pubitemid 30140165)